News

National Brain Tumor Society Welcomes the ReIntroduction of the Bolstering Research And Innovation Now (BRAIN) Act in Congress Bipartisan, bicameral legislation would increase research funding, foster collaboration, promote critical awareness efforts, and support innovations in and access to care National Brain Tumor Society, the largest patient advocacy organization in the United States committed to curing brain tumors and improving the lives of patients and families, applauds today’s reintroduction of the Bolstering Research And […] April 8, 2025

New Grants Aim to Improve Quality of Life for Patients with Brain Tumors and Their Caregivers  Today, the National Brain Tumor Society (NBTS) is announcing its first-ever Quality of Life Research grants, part of a concerted new program aimed at improving the lives of those facing brain tumors, both patients and their caregivers. The new grants, supported in part by Stachestrong, will fund two projects, each for $200,000 over two years. […] March 17, 2025

National Brain Tumor Society Celebrates the Introduction of the Bipartisan Bolstering Research and Innovations Now (BRAIN) Act in Congress Landmark legislation aims to invest in research, foster collaboration, improve survivorship and quality of life, and raise awareness of key treatment considerations National Brain Tumor Society, the largest patient advocacy organization in the United States committed to curing brain tumors and improving the lives of patients and families, is proud to share that a once-in-a-generation […] July 23, 2024

World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative   Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023

National Brain Tumor Society Launches DNA Damage Response Consortium with Yale Consortium seeks to advance underdeveloped area of brain cancer research, advance drug development, and improve treatment options for patients Today, the National Brain Tumor Society (NBTS) announced the launch of its new flagship research initiative, the DNA Damage Response Consortium, in partnership with Yale Cancer Center. The consortium will bring together a diverse team of […] February 22, 2022